4.4 Article

Atypical chemokine receptors: from silence to sound

Journal

BIOCHEMICAL SOCIETY TRANSACTIONS
Volume 41, Issue -, Pages 231-236

Publisher

PORTLAND PRESS LTD
DOI: 10.1042/BST20120246

Keywords

beta-arrestin; atypical chemokine receptor; chemokine; G-protein

Funding

  1. European Community [HEALTH-F4-2011-281608 (TIMER)]
  2. Ministero dell'Istruzione dell'Universita e della Ricerca [Progetti di Ricerca di Interesse Nazionale (PRIN)] [2002061255, 2007-ENYMAN-003]
  3. Ministero dell'Istruzione dell'Universita e della Ricerca [Fondo per gli Investimenti della Ricerca di Base (FIRB)] [RBFR08CW8G]
  4. Fondo Humanitas per la Ricerca
  5. Italian Association for Cancer Research (AIRC)

Ask authors/readers for more resources

ACRs (atypical chemokine receptors) were initially referred to as 'silent' receptors on the basis of a lack of signalling and functional activities that are typically observed with conventional chemokine receptors. Although ACRs do not directly induce cell migration, they indirectly control leucocyte recruitment by shaping chemokine gradients in tissues through degradation, transcytosis or local concentration of their cognate ligands. Recent evidence also suggests that these biological activities are supported by G-protein-independent, beta-arrestin-dependent signalling events. In the present article, we review current knowledge on structural and signalling properties of ACRs that are changing our view on this entire class of receptors from silent to endogenous beta-arrestin-biased signalling receptors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available